Aromasin and exemestane refer to the same substance, but the difference lies in the context and naming convention:
1.Aromasin: This is the brand name for the drug. It is manufactured and marketed by Pfizer, and it is commonly prescribed for the treatment of breast cancer in postmenopausal women. Aromasin is the trade name used by the pharmaceutical company when promoting the drug to healthcare providers and patients.
2.Exemestane: This is the generic name for the active ingredient in Aromasin. It is the chemical name used to describe the compound itself, which is an aromatase inhibitor. Exemestane works by inhibiting the enzyme aromatase, which is responsible for converting androgens (male hormones) into estrogens (female hormones). By lowering estrogen levels, exemestane helps in preventing the growth of hormone-sensitive breast cancer cells.
Summary:
●Aromasin = Brand name.
●Exemestane = Generic (active ingredient) name.
Both refer to the same medication used to treat hormone receptor-positive breast cancer in postmenopausal women by reducing estrogen production. However, Aromasin is the marketed version, while exemestane is the underlying chemical.
